Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.

@article{Speiser1998EffectsON,
  title={Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.},
  author={Zipora Speiser and Ross Levy and Samia Cohen},
  journal={Journal of neural transmission. Supplementum},
  year={1998},
  volume={52},
  pages={287-300}
}
N-propargyl-1-(R)aminoindan (rasagiline) is a new and selective irreversible MAO-B inhibitor, currently being considered as the mesylate salt for potential therapy in certain neurological disorders. It has been studied in animal models of cognition and motor dysfunction. Its ability to restore normal motor activity was determined in models of acute drug-induced dopaminergic dysfunction: Its effects in improving cognition and memory deficits was studied in adult and senescent rats that had been… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Rasagiline in treatment of Parkinson’s disease

Neuropsychiatric disease and treatment • 2008
View 1 Excerpt
Highly Influenced

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

Archives of neurology • 2002
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…